Tagged in

Garth Cumberlidge

Inovia Conversations

Thoughts and insights on building impactful and enduring companies and enjoying the journey — from the Inovia Capital team.

More information

Followers

2.3K

Elsewhere

More, on Medium

Garth Cumberlidge

Inovia Capital in Inovia Conversations

Jul 18, 2013

BAUSCH + LOMB + MIMETOGEN : Pioneered and proved the efficacy of “Virtual Project Management”

Even though Inovia Capital doesn’t do Life Sciences investments anymore (since 2009), we still have two amazing bio-pharma portfolio companies under management, and we…

Inovia Capital in Inovia Conversations

Feb 25, 2011

Medwell Capital Announces $2 Million Investment in Mimetogen Pharmaceuticals

Medwell Capital Announces $2 Million Investment in Mimetogen Pharmaceuticals

Mimetogen Pharmaceuticals Enrolls 100th Patient in Phase II Clinical Trial for Dry Eye

Inovia Capital in Inovia Conversations

Oct 7, 2009

Mimetogen Pharmaceuticals Completes Key Equity Financing

Mimetogen Pharmaceuticals Completes Key Equity Financing

Montréal, Québec — October 7th, 2009 — Mimetogen Pharmaceuticals Inc. (“Mimetogen”), a privately held drug development company announced today that…

Inovia Capital in Inovia Conversations

Mar 23, 2006

Mimetogen Pharmaceuticals Inc. Closes Series A Financing and Completes Exclusive Licensing Agreement with McGill University

Mimetogen Pharmaceuticals Inc. Closes Series A Financing and Completes Exclusive Licensing Agreement with McGill…

Inovia Capital in Inovia Conversations

Nov 28, 2005

Mimetogen Pharmaceuticals Inc. Secures Seed Financing from MSBi Capital

Mimetogen Pharmaceuticals Inc. Secures Seed Financing from MSBi Capital

Montréal, Québec — November 28th, 2005